ArticleCancers2025
Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD Cirrhosis.
Mohammad Jarrah, Sneha Deodhar, Lisa Quirk, Mohammed Al-Hasan, Ashish Sharma, Guruveer Bhamra, Julia Terrell, Fasiha Kanwal, Yujin Hoshida, Nicole E Rich and 2 more
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Mohammad JarrahDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.ORCID 0000-0002-2816-5689 Sneha DeodharDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Lisa QuirkDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Mohammed Al-HasanDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Ashish SharmaClinical Development and Medical Affairs, Roche Diagnostics International AG, 6343 Rotkreuz, Switzerland.ORCID 0000-0003-3610-0081 Guruveer BhamraDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.ORCID 0009-0009-1608-6949 Julia TerrellDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Fasiha KanwalDepartment of Internal Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Yujin HoshidaDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.ORCID 0000-0001-9430-1426 Nicole E RichDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Purva GopalDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Amit G SingalDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA.
Funding
UT Southwestern Liver Cancer SPOREP50CA295495 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Yujin Hoshida, Amit Singal · 2025 to 2026
$7.5MTrial of Statins for Chemoprevention in Hepatocellular CarcinomaR01CA255621 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHUNG, RAYMOND T, HOSHIDA, YUJIN · 2021 to 2025
$3.6MReverse-engineering precision liver cancer chemopreventionR01CA233794 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HOSHIDA, YUJIN · 2019 to 2023
$3.5MNon-invasive etiology-adjusted precision liver cancer risk predictionR01CA292930 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HOSHIDA, YUJIN · 2025 to 2025
$2.9MEpigallocatechin gallate for prevention of lethal cirrhosis complicationsR01CA282178 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Yujin Hoshida, Amit Singal · 2023 to 2026
$1.8MCancer Prevention and Research Institute of Texas RP200554NCI NIH HHS P50 CA295495NCI NIH HHS R01 CA233794NCI NIH HHS R01 CA255621NCI NIH HHS R01 CA282178NCI NIH HHS R01 CA292930NIH HHS 1P50CA295495-01NIH HHS 1U24CA086368-25NIH HHS 4U01CA283935-03NIH HHS 5U01CA271887-04
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomarkersGAADGALADhepatocellular carcinomascreening
Identifiers
PMID41375033
PMCPMC12691257
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390